Literature DB >> 12118008

Macrophage foam cell formation with native low density lipoprotein.

Howard S Kruth1, Wei Huang, Itsuko Ishii, Wei-Yang Zhang.   

Abstract

This investigation has elucidated a mechanism for development of macrophage foam cells when macrophages are incubated with native low density lipoprotein (LDL). LDL is believed to be the main source of cholesterol that accumulates in monocyte-derived macrophages within atherosclerotic plaques, but native LDL has not previously been shown to cause substantial cholesterol accumulation when incubated with macrophages. We have found that activation of human monocyte-derived macrophages with phorbol 12-myristate 13-acetate (PMA) stimulates LDL uptake and degradation and acyl-CoA:cholesterol acyltransferase-mediated esterification of LDL-derived cholesterol, resulting in massive macrophage cholesterol accumulation that could exceed 400 nmol/mg of cell protein. Cholesterol accumulation showed a biphasic linear LDL concentration dependence with LDL levels as high as 4 mg/ml, similar to LDL levels in artery intima. Protein kinase C mediated the PMA-stimulated macrophage uptake of LDL because the protein kinase C inhibitors, Gö6983 and GF109203X, inhibited cholesterol accumulation. LDL receptors did not mediate macrophage cholesterol accumulation because accumulation occurred with reductively methylated LDL and in the presence of an anti-LDL receptor-blocking monoclonal antibody. LDL-induced cholesterol accumulation was not inhibited by antioxidants, was not accompanied by increased LDL binding to macrophages, did not depend on the apoB component of LDL, and was not down-regulated by prior cholesterol enrichment of macrophages. We have shown that the mechanism of LDL uptake by macrophages was PMA-stimulated endocytosis of LDL taken up as part of the bulk phase fluid (i.e. fluid phase endocytosis). The amount of LDL taken up with the bulk phase fluid was measured with [(3)H]sucrose and accounted for a minimum of 83% of the LDL cholesterol delivery and accumulation in PMA-activated macrophages. This novel mechanism of macrophage cholesterol accumulation shows that modification of LDL is not necessary for foam cell formation to occur. In addition, the findings direct attention to macrophage fluid phase endocytosis as a relevant pathway to target for modulating macrophage cholesterol accumulation in atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12118008     DOI: 10.1074/jbc.M205059200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

1.  CD11c/CD18 expression is upregulated on blood monocytes during hypertriglyceridemia and enhances adhesion to vascular cell adhesion molecule-1.

Authors:  R Michael Gower; Huaizhu Wu; Greg A Foster; Sridevi Devaraj; Ishwarlal Jialal; Christie M Ballantyne; Anne A Knowlton; Scott I Simon
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-10-28       Impact factor: 8.311

2.  Targeting Innate Immunity for CV Benefit.

Authors:  Kathryn J Moore; Mason W Freeman
Journal:  Drug Discov Today Ther Strateg       Date:  2008

3.  Inflammatory stress increases unmodified LDL uptake via LDL receptor: an alternative pathway for macrophage foam-cell formation.

Authors:  Qiang Ye; Yaxi Chen; Han Lei; Qing Liu; John F Moorhead; Zac Varghese; Xiong Z Ruan
Journal:  Inflamm Res       Date:  2009-06-17       Impact factor: 4.575

Review 4.  Oxidized LDL: diversity, patterns of recognition, and pathophysiology.

Authors:  Irena Levitan; Suncica Volkov; Papasani V Subbaiah
Journal:  Antioxid Redox Signal       Date:  2010-07-01       Impact factor: 8.401

Review 5.  Receptor-independent fluid-phase pinocytosis mechanisms for induction of foam cell formation with native low-density lipoprotein particles.

Authors:  Howard S Kruth
Journal:  Curr Opin Lipidol       Date:  2011-10       Impact factor: 4.776

6.  Identification of novel macropinocytosis inhibitors using a rational screen of Food and Drug Administration-approved drugs.

Authors:  Hui-Ping Lin; Bhupesh Singla; Pushpankur Ghoshal; Jessica L Faulkner; Mary Cherian-Shaw; Paul M O'Connor; Jin-Xiong She; Eric J Belin de Chantemele; Gábor Csányi
Journal:  Br J Pharmacol       Date:  2018-08-01       Impact factor: 8.739

7.  PKCδ stimulates macropinocytosis via activation of SSH1-cofilin pathway.

Authors:  Bhupesh Singla; Hui-Ping Lin; Pushpankur Ghoshal; Mary Cherian-Shaw; Gábor Csányi
Journal:  Cell Signal       Date:  2018-09-24       Impact factor: 4.315

8.  Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice.

Authors:  Kathryn J Moore; Vidya V Kunjathoor; Stephanie L Koehn; Jennifer J Manning; Anita A Tseng; Jessica M Silver; Mary McKee; Mason W Freeman
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

9.  Changes in macrophage function modulated by the lipid environment.

Authors:  Michael R Williams; David M Cauvi; Isabel Rivera; Dennis Hawisher; Antonio De Maio
Journal:  Innate Immun       Date:  2016-03-07       Impact factor: 2.680

10.  Effects of rosiglitazone on native low-density-lipoprotein-induced respiratory burst in circulating monocytes and on the leukocyte-endothelial interaction in cholesterol-fed rats.

Authors:  Long Sheng Lu; Li Man Hung; Chang Hui Liao; Chau Chung Wu; Ming Jai Su
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-04-21       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.